Sandra Levy
ARTICLES BY THIS AUTHOR
- 2/21/2023
Walmart unveils Walmart Business
Walmart Business is an e-commerce site and customer experience designed to empower SMB and nonprofit customers. - 2/21/2023
Amazon completes $3.9B deal to acquire One Medical
One Medical offers in-office and 24/7 virtual care services, on-site labs and programs for preventive care, chronic care management, common illnesses and mental health concerns. - 2/20/2023
Kroger, Albertsons reportedly moving forward on plans to divest stores
The stores that Kroger and Albertsons reportedly may sell are estimated to be worth more than $1 billion, according to a Reuters report. - 2/20/2023
AAM names 2023 board of directors
Christine Baeder, senior vice president and chief operating officer for U.S. generics, Teva Pharmaceuticals USA is the 2023 AAM chair of the board. - 2/20/2023
Market Performance Group mourns passing of Rhonda Johnson
Johnson was a respected and dynamic consumer packaged goods and healthcare leader who held senior executive positions with various companies. - 2/20/2023
Alembic launches generic Latuda
Generic Latuda is used to treat a depressive episode associated with Bipolar I Disorder (bipolar depression) in adults and pediatric patients as monotherapy. - 2/20/2023
Amgen intros Humira biosimilar
Amgen's Amjevita is the first U.S. biosimilar to AbbVie's Humira. - 2/16/2023
Stemline Therapeutics receives FDA OK for Orserdu
Orserdu (elacestrant) is the first and only treatment specifically indicated for patients with ESR1 Mutations in ER+, HER2- advanced or metastatic breast cancer. - 2/15/2023
FDA gives Merck green light for new indication for Keytruda
Keytruda is now approved as a single agent for adjuvant treatment following surgical resection and platinum-based chemotherapy for adult patients with stage IB (T2a ≥4 centimeters [cm]), II, or IIIA non-small cell lung cancer. - 2/14/2023
Alembic intros generic Taxol
Paclitaxel injection solution is indicated for several different types of cancer.
